Serious adverse event | Events/100 patient-years | |
---|---|---|
ARMADA blinded period* | ARMADA total exposure† | |
*87 patient-years of total exposure; †886 patient-years of total exposure (as of 31 August 2004). | ||
Serious infections | 2.30 | 2.03 |
Pneumonia | 2.30 | 0.56 |
Urinary tract infections | 0.00 | 0.23 |
Septic arthritis | 0.00 | 0.11 |
Tuberculosis | 0.00 | 0.00 |
Histoplasmosis | 0.00 | 0.00 |
Demyelinating diseases | 0.00 | 0.11 |
Lymphoma | 0.00 | 0.00 |
SLE/lupus-like syndrome | 0.00 | 0.00 |
Congestive heart failure | 0.00 | 0.11 |
Pancytopenia | 0.00 | 0.00 |